Analyte Sensor Partner Interface for Interoperable Glucose Data Links

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional systems for managing diabetes through wireless communication of analyte data face challenges in interoperability, flexibility, and adaptability across devices from different manufacturers, particularly in maintaining synchronized analyte data communication and managing devices that regulate blood glucose levels.

Innovation Solution

A diabetes management partner interface is used to configure an analyte sensor system for wireless communication with partner devices, allowing for setting or modifying configuration parameters such as wireless connectivity, access control, and analyte data parameters based on system requirements, including battery capacity, accuracy, communication protocols, and regulatory requirements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional SMBG monitors are used for blood glucose monitoring, then the device structure is simple and easy to manufacture, but the measurement frequency is limited (2-4 times per day) and the timeliness of glucose level information is insufficient

Engineering Contradiction:
Improvetimeliness of glucose level informationVSAvoiddevice structure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical finger-pricking method with a transdermal electrochemical sensor system that uses electrical signals to detect glucose levels continuously through the skin, eliminating the need for repeated mechanical punctures and enabling real-time monitoring without increasing structural complexity significantly

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a remote device as an intermediary that receives analyte data from the sensor system via wireless transmission and provides processed glucose level information to the user, separating the sensing function from the display and processing functions to improve timeliness while managing complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If implantable sensors are used for continuous analyte detection, then the timeliness of glucose level information is improved, but interoperability issues arise with devices from different manufacturers and regulatory requirements become more stringent

Engineering Contradiction:
Improvecontinuous analyte detection capabilityVSAvoidinteroperability with multiple devices
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent implements a universal interface architecture that allows the analyte sensor system to communicate with multiple types of partner devices (insulin pumps, CGMs, mobile devices) from different manufacturers through standardized communication protocols, enabling one sensor system to serve multiple functions and integrate with various diabetes management devices

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent employs configurable communication parameters that can be adjusted to meet different regulatory requirements and device specifications, allowing the system to adapt its transmission protocols, data formats, and security settings to work seamlessly with partner devices from various manufacturers while maintaining continuous detection capability

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple partner devices are connected to the analyte sensor system, then the versatility of the system is improved, but the device complexity and difficulty of maintaining synchronized communication increase

Engineering Contradiction:
Improvenumber of connectable devicesVSAvoidcommunication synchronization complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent divides the communication management into distinct functional modules: a partner device manager component that handles device pairing and authorization, a data synchronization module that coordinates information exchange, and individual communication interfaces for each device type, reducing the overall complexity by organizing the multi-device communication system into manageable segments

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12519795B2Diabetes management partner interface for wireless communication of analyte data
Publication Date: 2026.01.06 DEXCOM INC
  • US12519795B2 patent drawing
  • US12519795B2 patent drawing
  • US12519795B2 patent drawing

AI summary

Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.